FIELD: pharmacology.
SUBSTANCE: claimed invention relates to novel application of lignan compounds represented by formula I, given in description. In particular claimed invention relates to pharmaceutical composition for treatment or prevention of brain disease, which contains lignan compound, represented by formula I or Myristica fragrans extract as active ingredient, as well as method and application for treatment or prevention of brain disease with application of lignan compound. Lignan compound represented by formula I possesses anti-oxidative, protective for brain cells and anti-inflammatory effect.
EFFECT: lignan compound will be useful for treatment or prevention of brain diseases.
14 cl, 16 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL APOPTOSIS OR NEURODEGENERATION | 2011 |
|
RU2586772C2 |
| COMPOSITIONS, METHODS AND MEDICAL COMPOSITIONS FOR TREATMENT AND MAINTENANCE OF LIVER HEALTH | 2016 |
|
RU2755475C2 |
| PHARMACEUTICAL COMPOSITION FOR INHIBITING APOPTOSIS OF NEURONS OR NEURODEGENERATION | 2011 |
|
RU2722018C2 |
| PEPTIDE COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE | 2021 |
|
RU2816119C1 |
| APPLICATION OF K-252A DERIVATIVES TO TREAT DISORDERS OF PERIPHERAL OR CENTRAL NERVOUS SYSTEMS AND EXCESSIVE CYTOKINE OUTPUT | 1997 |
|
RU2183959C2 |
| METHODS OF TREATING LEUKOPENIA AND THROMBOCYTOPENIA | 2015 |
|
RU2702122C2 |
| MEDICINAL PRODUCT APHANZOMENON FLOS AQUAE, EXTRACTS AND PURIFIED COMPONENTS OF EXTRACTIONS FOR TREATMENT OF NEUROLOGIC, NEURODEGENERATIVE AND AFFECTIVE DISORDERS | 2007 |
|
RU2441663C2 |
| METHOD FOR APPLYING XENON FOR TREATING NEUROINTOXICATION | 2000 |
|
RU2246949C2 |
| INTERLEUKIN-10, USING IT AND BASED COMPOSITION FOR TREATING BRAIN NEURODEGENERATIVE PROCESSES | 2012 |
|
RU2538613C2 |
| COMPOSITIONS AND METHODS OF USING PHORBOL ESTERS | 2013 |
|
RU2659684C2 |
